Free Trial

Cognex Corporation $CGNX Stock: Asset Management One Co. Ltd. Cuts Holdings

Cognex logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Asset Management One reduced its Cognex position by 36.8% in the third quarter, selling 20,460 shares and retaining 35,115 shares valued at approximately $2.13 million. Institutional investors collectively own 88.12% of CGNX.
  • Analyst sentiment remains moderately bullish, with a consensus rating of “Moderate Buy” and an average price target of $75.57, although recent targets have varied from $70 to $84.
  • Cognex reported quarterly EPS of $0.45, beating estimates by $0.03, while revenue rose 16.9% year over year to $291.26 million. The company also announced a quarterly dividend of $0.085 per share, equivalent to a 0.6% annualized yield.
  • Interested in Cognex? Here are five stocks we like better.

Asset Management One Co. Ltd. decreased its position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 36.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 35,115 shares of the scientific and technical instruments company's stock after selling 20,460 shares during the quarter. Asset Management One Co. Ltd.'s holdings in Cognex were worth $2,130,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. SYM FINANCIAL Corp increased its position in shares of Cognex by 6.3% in the 3rd quarter. SYM FINANCIAL Corp now owns 3,372 shares of the scientific and technical instruments company's stock valued at $204,000 after buying an additional 201 shares in the last quarter. Park Avenue Securities LLC raised its stake in Cognex by 4.4% during the 3rd quarter. Park Avenue Securities LLC now owns 9,862 shares of the scientific and technical instruments company's stock worth $598,000 after buying an additional 414 shares during the period. Verdence Capital Advisors LLC bought a new position in Cognex during the third quarter worth about $221,000. Peterson Wealth Services lifted its holdings in Cognex by 25.0% during the third quarter. Peterson Wealth Services now owns 6,355 shares of the scientific and technical instruments company's stock worth $385,000 after acquiring an additional 1,269 shares in the last quarter. Finally, Apollon Wealth Management LLC lifted its holdings in Cognex by 10.1% during the third quarter. Apollon Wealth Management LLC now owns 3,510 shares of the scientific and technical instruments company's stock worth $213,000 after acquiring an additional 323 shares in the last quarter. Institutional investors and hedge funds own 88.12% of the company's stock.

Analyst Upgrades and Downgrades

CGNX has been the subject of a number of research analyst reports. Citigroup reissued a "neutral" rating and issued a $74.00 target price (up from $72.00) on shares of Cognex in a research note on Friday, August 7th. Cantor Fitzgerald lifted their price objective on Cognex from $76.00 to $84.00 and gave the company an "overweight" rating in a report on Friday, August 7th. Wall Street Zen cut Cognex from a "buy" rating to a "hold" rating in a report on Sunday, September 13th. Weiss Ratings raised shares of Cognex from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. Finally, Robert W. Baird reduced their price target on Cognex from $78.00 to $70.00 and set a "neutral" rating for the company in a research report on Wednesday, September 23rd. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $75.57.

View Our Latest Analysis on CGNX

Cognex Trading Up 0.5%

NASDAQ CGNX opened at $56.41 on Tuesday. Cognex Corporation has a 12 month low of $34.60 and a 12 month high of $72.88. The stock has a 50 day moving average of $59.79 and a 200-day moving average of $57.81. The company has a market cap of $9.49 billion, a PE ratio of 47.89 and a beta of 1.48.

Cognex (NASDAQ:CGNX - Get Free Report) last issued its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts' consensus estimates of $0.42 by $0.03. The business had revenue of $291.26 million for the quarter, compared to the consensus estimate of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The firm's revenue for the quarter was up 16.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.25 earnings per share. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, sell-side analysts predict that Cognex Corporation will post 1.68 EPS for the current fiscal year.

Cognex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th were issued a $0.0850 dividend. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Thursday, August 20th. Cognex's dividend payout ratio is presently 33.01%.

Cognex Profile

(Free Report)

Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.

The company's product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.

Featured Stories

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines